St Jude near finish in ANS (Advanced Neuromodulation Systems) acquisition:
This article was originally published in Clinica
Executive Summary
St Jude Medical's path to acquiring Advanced Neuromodulation Systems (ANS) is now clear after the deal received final foreign antitrust clearance on Friday (November 11). The German Federal Cartel Office gave the St Paul, Minnesota company the go-ahead just a week after the US Federal Trade Commission approved the proposed $1.3bn acquisition (see Clinica No 1181, p 16). No other regulatory approvals are required for the merger, which is expected to close by the end of the year.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.